Sign in
4/A

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-008804

Director bought 9,500 shares at $14.34 ($136,230)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peyer James Director 2021-03-23 Purchase +9,500 $14.34 $136,230 4,798,293 I: show line 1 in the form
Open-market purchases · 9,500 sh · avg $14.34 · $136,230
Loading xslF345X03/doc1.xml…